Vascular cognitive impairment topical collection on cardiovascular disease and stroke

Current Atherosclerosis Reports

Volumn 15, Issue 6, 2013, Pages

  Farooq, Muhammad U ^a   Gorelick, Philip B ^b  

^a Hauenstein Neuroscience Center   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cognitive impairment; Dementia; Stroke

Indexed keywords

CITICOLINE; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIET; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LIFESTYLE; MORBIDITY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SMOKING CESSATION; VASCULAR COGNITIVE IMPAIRMENT; WEIGHT CONTROL; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COMPLICATION; DEMENTIA, VASCULAR; MILD COGNITIVE IMPAIRMENT;

ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; HUMANS; MILD COGNITIVE IMPAIRMENT; RISK FACTORS; STROKE;

EID: 84891408603     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-013-0330-z     Document Type: Article

References (85)

1. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-713. This article is the offical statement of the American Heart Association and American Stroke Association on Vascular Cognitive Impairment. The American Academy of Neurology and the Alzheimer's Association have endorsed this statement. The guidance paper summarizes the existing evidence, gaps in our current understanding of the disorder, and also provides valuable recommendations for care of patients with vascular cognitive impairement.
2. Wetterling T, Kanitz RD, Borgis KJ. The ICD-10 criteria for vascular dementia. Dementia. 1994;5:185-8. (Pubitemid 24151544)
3. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia. 1994;5:189-92. (Pubitemid 24151545)
4. Jellinger KA. The enigma of mixed dementia. Alzheimers Dement. 2007;3:40-53. (Pubitemid 46076018)
5. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98. (Pubitemid 37443329)
6. Gons RA, de Laat KF, van Norden AG, et al. Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke. 2010;41:2801-6.
7. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008;63:72-80. (Pubitemid 351240553)
8. Dichgans M. Cognition in CADASIL. Stroke. 2009;40:S45-7.
9. Arvanitakis Z, Leurgans SE, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011;69:320-7.
10. Gregoire SM, Smith K, Jager HR, et al. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc Dis. 2012;33:430-5. This article provides further insight about the role of cerebral microbleeds, their relation to cognitive impairement and prognostic relevance for long-term cognitive outcome.
11. Fernando MS, Ince PG. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci. 2004;226:13-7. (Pubitemid 39505399)
12. Gasparovic C, Prestopnik J, Thompson J, et al. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment. J Neurol Neurosurg Psychiatry. 2013. This article highlightes the role of advanced imaging techniques in the diagnosis of VCI. The information obtained from these new techniques is unique and may prove to be valuable in the management of patients with VCI in the future.
13. Grysiewicz R, Gorelick PB. Key neuroanatomical structures for post-stroke cognitive impairment. Curr Neurol Neurosci Rep. 2012;12:703-8. This is a recent update on the neuroanatomical substrates of VCI.
14. Rosenberg GA. Inflammation and white matter damage in vascular cognitive impairment. Stroke. 2009;40:S20-3.
15. Adair JC, Charlie J, Dencoff JE, et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004;35:e159-62.
16. Simpson JE, Fernando MS, Clark L, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33:410-9. (Pubitemid 47037889)
17. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol. 2009;118:87-102.
18. Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006;66:23-9. (Pubitemid 43739586)
19. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003;34:335-7. (Pubitemid 36206315)
20. Sim FJ, Zhao C, Penderis J, et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci. 2002;22:2451-9. (Pubitemid 37465793)
21. Louissaint Jr A, Rao S, Leventhal C, et al. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 2002;34:945-60. (Pubitemid 34722284)
22. Nitkunan A, Lanfranconi S, Charlton RA, et al. Brain atrophy and cerebral small vessel disease: a prospective follow-up study. Stroke. 2011;42:133-8.
23. Gorelick PB, Pantoni L. Advances in vascular cognitive impairment. Stroke. 2013;44:307-8. This article provides insights about future research and new concepts of VCI in relation to small vessel disease and brain atrophy.
24. Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the canadian study of health and aging. Neurology. 2000;54:447-51.
25. Corrada MM, Brookmeyer R, Paganini-Hill A, et al. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010;67:114-21.
26. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54:S4-9.
27. Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22:575-80. (Pubitemid 32607742)
28. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM incidence research group. Neurology. 1999;53:1992-7.
29. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:195-204. (Pubitemid 38233480)
30. Rowan E, Morris CM, Stephens S, et al. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. Stroke. 2005;36:1864-8. (Pubitemid 41266515)
31. Viswanathan A, Patel P, Rahman R, et al. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke. 2008;39:1988-92.
32. del Valle J, Duran-Vilaregut J, Manich G, et al. Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice. Neurodegener Dis. 2011;8:421-9.
33. Greenberg SM, Gurol ME, Rosand J, et al. Amyloid angiopathy-related vascular cognitive impairment. Stroke. 2004;35:2616-9. (Pubitemid 39458351)
34. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310:970-3.
35. Kang JH, Grodstein F. Plasma carotenoids and tocopherols and cognitive function: a prospective study. Neurobiol Aging. 2008;29:1394-403. (Pubitemid 351970602)
36. Kang JH, Cook NR, Manson JE, et al. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the women's antioxidant and cardiovascular study. Circulation. 2009;119:2772-80.
37. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci. 2009;64:888-95.
38. Slinin Y, Paudel ML, Taylor BC, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010;74:33-41.
39. Scarmeas N, Stern Y, Mayeux R, et al. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66:216-25.
40. Sturman MT, Morris MC, Mendes de Leon CF, et al. Physical activity, cognitive activity, and cognitive decline in a biracial community population. Arch Neurol. 2005;62:1750-4. (Pubitemid 41626673)
41. Weuve J, Kang JH, Manson JE, et al. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292:1454-61. (Pubitemid 39258338)
42. Soumare A, Tavernier B, Alperovitch A, et al. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. J Gerontol A Biol Sci Med Sci. 2009;64:1058-65.
43. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002;25:295-301. (Pubitemid 34667010)
44. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35:2620-2. (Pubitemid 39458352)
45. Rincon F, Wright CB. Vascular cognitive impairment. Curr Opin Neurol. 2013;26:29-36.
46. Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31:780-6. (Pubitemid 28108576)
47. Gorelick PB. Can we save the brain from the ravages of midlife cardiovascular risk factors? Neurology. 1999;52:1114-5. (Pubitemid 29177906)
48. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56:1683-9. (Pubitemid 32574567)
49. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487-99. (Pubitemid 40982459)
50. McNay EC. The impact of recurrent hypoglycemia on cognitive function in aging. Neurobiol Aging. 2005;26 Suppl 1:76-9. (Pubitemid 41739431)
51. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005;28:71-7. (Pubitemid 40095785)
52. Saczynski JS, Jonsdottir MK, Garcia ME, et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol. 2008;168:1132-9.
53. Areosa SA, Grimley EV. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev. 2002:CD003804.
54. Solomon A, Kareholt I, Ngandu T, et al. Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging. 2009;30:1006-9.
55. Trompet S, van Vliet P, de Craen AJ, et al. Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol. 2010;257:85-90.
56. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000;20:2255-60.
57. Rusanen M, Kivipelto M, Quesenberry Jr CP, et al. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med. 2011;171:333-9.
58. Wright CB, Elkind MS, Rundek T, et al. Alcohol intake, carotid plaque, and cognition: the Northern Manhattan Study. Stroke. 2006;37:1160-4. (Pubitemid 43731855)
59. Elias PK, Elias MF, D'Agostino RB, et al. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol. 1999;150:580-9. (Pubitemid 29426902)
60. Demarin V, Zavoreo I, Kes VB. Carotid artery disease and cognitive impairment. J Neurol Sci. 2012;322:107-11.
61. Sander K, Bickel H, Forstl H, et al. Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study. Int J Geriatr Psychiatry. 2010;25:389-94.
62. Komulainen P, Kivipelto M, Lakka TA, et al. Carotid intima-media thickness and cognitive function in elderly women: a population-based study. Neuroepidemiology. 2007;28:207-13. (Pubitemid 47573715)
63. Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Hear Rhythm. 2010;7:433-7.
64. Dublin S, Anderson ML, Haneuse SJ, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59:1369-75.
65. Kalantarian S, Stern TA, Mansour M, et al. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013;158:338-46. This article provides a comprehensive review and analysis of currently avaialble data about the association of atrial fibrillation and cognitive impairement.
66. Barber M, Tait RC, Scott J, et al. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost. 2004;2:1873-8. (Pubitemid 40192736)
67. Ezekowitz MD, James KE, Nazarian SM, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in nonrheumatic atrial fibrillation investigators. Circulation. 1995;92:2178-82.
68. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4:363-81. (Pubitemid 351711965)
69. Price JF, McDowell S, Whiteman MC, et al. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc. 2006;54:763-9. (Pubitemid 44030197)
70. Laurin D, Masaki KH, White LR, et al. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation. 2007;116:2269-74. (Pubitemid 350100332)
71. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65:545-51. (Pubitemid 41170713)
72. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292:2901-8. (Pubitemid 39628238)
73. Gorelick PB, Nyenhuis DL, Garron DC, et al. Is vascular dementia really Alzheimer's disease or mixed dementia? Neuroepidemiology. 1996;15:286-90. (Pubitemid 26356747)
74. Selnes OA, Vinters HV. Vascular cognitive impairment. Nat Clin Pract Neurol. 2006;2:538-47. (Pubitemid 44445810)
75. Gold CA, Budson AE. Memory loss in Alzheimer's disease: implications for development of therapeutics. Expert Rev Neurother. 2008;8:1879-91.
76. Jellinger KA. Morphologic diagnosis of vascular dementia - a critical update. J Neurol Sci. 2008;270:1-12.
77. Cordoliani-Mackowiak MA, Henon H, Pruvo JP, et al. Poststroke dementia: influence of hippocampal atrophy. Arch Neurol. 2003;60:585-90. (Pubitemid 36427973)
78. Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34:2323-30. (Pubitemid 37221934)
79. Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61:479-86. (Pubitemid 37025364)
80. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004:CD004395.
81. Auchus AP, Brashear HR, Salloway S, et al. Galantamine treatment of vascular dementia: a randomized trial. Neurology. 2007;69:448-58. (Pubitemid 47450280)
82. Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002;359:1283-90. (Pubitemid 34310633)
83. Craig D, Birks J. Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev. 2005:CD004744.
84. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006:CD003154.
85. Cotroneo AM, Castagna A, Putignano S, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging. 2013;8:131-7.